NHS cancer services have faced growing pressure in recent years, leading to delays in diagnosis and treatment.

Government cancer waiting time standards measure whether NHS England is meeting targets for timely care and reflect current system pressures.

Faster testing and early treatment are linked to better outcomes for patients. December 2023 saw the first report using new NHS England cancer waiting time targets, with three key standards indicating service performance. Cancer Research UK’s latest article presents the October 2025 results for England:

The Faster Diagnosis Standard: Target Met

  • 76.1% of people were diagnosed, or had cancer ruled out, within 28 days of an urgent referral in March 2025. The target is 75%.

The 62-day referral to treatment standard: Target Missed

  • Only 68.8% of people in England received their diagnosis and started their first treatment within 2 months (or 62 days) of an urgent referral in July 2025. The target is 85% and has not been met since December 2015.

The 31-day decision to treat standard: Target Missed

  • 92.5% of people started treatment within 31 days of doctors deciding a treatment plan in July 2025. The target is 96%.

The above data are specific to England. Scotland, Wales and Northern Ireland also have their own cancer waiting times targets. 

What does this mean for people affected by cancer?

Behind these numbers are people experiencing significant anxiety. Cancer data varies by type of cancer; some cancers are more aggressive, so patients with these get prioritised for early treatment when possible.

There are valid reasons for differences in waiting times. Planning curative treatments can take longer, and some patients need preparation before starting therapy to improve recovery.

Missed targets are concerning because they mean people wait longer for vital cancer treatments. Still, delays should not discourage anyone from seeing a doctor if symptoms arise – being on the waiting list is always preferable, and doctors expedite urgent cases wherever possible.

Getting back on track

The FDS target was met this month, mainly due to more cancer cases being ruled out, not faster diagnoses.

According to Cancer Research UK analysis, timely diagnosis rates after urgent referral have dropped since 2021, highlighting the need for greater diagnostic capacity.

Many patients still wait too long for treatment, which can raise anxiety and affect outcomes for aggressive cancers. While we appreciate the government’s aims in NHS England’s Medium Term Planning Framework, continued commitment must be shown in the National Cancer Plan for England. Lasting change will require sufficient funding and strong oversight.

Read more on Cancer Research UK’s website here